Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr. Reddy's Scouts for Partner to Enter Japanese Market (Japan)

This article was originally published in PharmAsia News

Executive Summary

Dr Reddy's Laboratories is looking for a partner to help it enter the Japanese market. The second largest pharmaceutical market in the world, Japan represents 11 percent of global sales. Currently, only a small percentage of those are generics but as healthcare costs skyrocket that may be changing. In 2006, generic drug sales climbed 5.1 percent even though the market as a whole fell slightly. Dr. Reddy's is the latest Indian company to target the expanding Japanese generics market. Ranbaxy Laboratories teamed up with Nippon Chemiphar in 2005, and just last week Lupin said it would acquire Kyowa Pharmaceuticals. Cadila Healthcare also took control of Nippon Universal Pharmaceuticals earlier in 2007. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts